Names & News

Martin J. Edelman has been appointed Chairman of the Department of Hematology/Oncology and Deputy Director for Clinical Research at the Fox Chase Cancer Center in Philadelphia. He will also be the G. Morris Dorrance Professor of Hematology/Oncology. Prior to joining Fox Chase, Dr. Edelman was Head of the Section of Solid Tumor Oncology and Associate Director…

Dr. Philip Bonomi completed his service as Director of the Division of Hematology, Oncology and Cell Therapy at Rush University Medical Center, Chicago, US, a position he has held since 2002. Professor Bonomi is the Alice Pirie Wirtz Professor of Medical Oncology at Rush, where he continues his work as a lung cancer researcher and…

David Ball was appointed Director of the Lung Tumour Stream for The Royal Melbourne Hospital, The Royal Women’s Hospital and the Peter MacCallum Cancer Centre, which are now part of the Victorian Comprehensive Cancer Centre Alliance. As reported in issue #3 of IASLC Lung Cancer News, the Peter MacCallum Cancer Centre recently moved into new…

The lung cancer research community lost a respected leader and significant contributor to the field with the passing of Robert B. Livingston, MD, a Professor of Medicine and Hematology-Oncology at the University of Arizona Cancer Center. He died at home in Tucson, Arizona, on September 8, 2016, at age 75. Dr. Livingston embarked on his…

Glen Weiss, MD, MBA, was named 2016 Healthcare Leadership Awards’ Researcher of the Year by AZ Business magazine. Dr. Weiss is Director of Clinical Research, Director of Phase I and II Clinical Trials, Cancer Treatment Centers of America, Arizona, US, and is Clinical Associate Professor at University of Arizona College of Medicine.

David Spigel has been appointed chief scientific officer of Sarah Cannon Research Institute, Nashville, US, and will oversee the development and operations of Sarah Cannon’s clinical research program. Dr. Spigel joined Sarah Cannon in 2003 as the director of the lung cancer research program.

Mark A. Socinski has been appointed Executive Medical Director of the Florida Hospital Cancer Institute, and will oversee the coordination of clinical cancer services for the Florida Hospital network. He will also be a member of the Institute’s Thoracic Oncology Program. Dr. Socinski was previously Professor of Medicine and Cardiovascular Surgery; Director of the Lung Cancer…

David H. Johnson received the 2016 ASCO Distinguished Achievement Award, which is given annually and recognizes leadership or mentorship by a scientist, practitioner, or researcher who has benefited patients with cancer or those who treat them. Dr. Johnson is Chairman of the Department of Internal Medicine at The University of Texas (UT) Southwestern Medical Center, Dallas,…

Laurie Fenton Ambrose received the 2016 James L. Mulshine, MD Leadership Award, which recognized her efforts in guiding patient advocacy and other stakeholder groups in the successful efforts to gain coverage of lung cancer screening by the Centers for Medicare & Medicaid Services (CMS). Ms. Ambrose is President and CEO of the Lung Cancer Alliance.

Jeffrey Engelman has been appointed Vice President and Global Head of Oncology at the Novartis Institutes of BioMedical Research. Prior to joining Novartis, Dr. Engelman was Director of the Center for Thoracic Oncology and Molecular Therapeutics at Massachusetts General Hospital, Boston, US, and Harvard Medical School professor.